In the study conducted by Liu et al (12), the serum MCP-1 levels were measured in 112 patients with SLE, 30 patients with rheumatoid arthritis, 11 non-SLE patients with renal impairment, and 40 healthy volunteers. This evidence concerns the gene CCL2 and systemic lupus erythematosus.